To date, many epidemiological studies have been performed to evaluate the association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk, but the results remain conflicting rather than conclusive. Here, APEX1 is linked to breast carcinoma.